ATE245647T1 - Gegebenenfalls geschützte 3- hydroxymethylcarbapeneme und ihre synthese - Google Patents

Gegebenenfalls geschützte 3- hydroxymethylcarbapeneme und ihre synthese

Info

Publication number
ATE245647T1
ATE245647T1 AT98943333T AT98943333T ATE245647T1 AT E245647 T1 ATE245647 T1 AT E245647T1 AT 98943333 T AT98943333 T AT 98943333T AT 98943333 T AT98943333 T AT 98943333T AT E245647 T1 ATE245647 T1 AT E245647T1
Authority
AT
Austria
Prior art keywords
synthesis
hydroxymethylcarbapenems
optionally protected
formula
protecting group
Prior art date
Application number
AT98943333T
Other languages
English (en)
Inventor
John Y Chung
Johnnie L Leazer Jr
Nobuyoshi Yasuda
Mark S Jensen
Kenneth M Wells
Chunhua Yang
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9800459.1A external-priority patent/GB9800459D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE245647T1 publication Critical patent/ATE245647T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98943333T 1997-08-26 1998-08-21 Gegebenenfalls geschützte 3- hydroxymethylcarbapeneme und ihre synthese ATE245647T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5696797P 1997-08-26 1997-08-26
GBGB9800459.1A GB9800459D0 (en) 1998-01-09 1998-01-09 Crystalline 2-hydroxymethyl carbapenem intermediate compounds and process for synthesis thereof
PCT/US1998/017467 WO1999010348A1 (en) 1997-08-26 1998-08-21 Optionally protected 3-hydroxymethyl carbapenems and synthesis

Publications (1)

Publication Number Publication Date
ATE245647T1 true ATE245647T1 (de) 2003-08-15

Family

ID=26312921

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98943333T ATE245647T1 (de) 1997-08-26 1998-08-21 Gegebenenfalls geschützte 3- hydroxymethylcarbapeneme und ihre synthese

Country Status (8)

Country Link
EP (1) EP1015452B1 (de)
JP (1) JP3386452B2 (de)
AT (1) ATE245647T1 (de)
AU (1) AU731494B2 (de)
CA (1) CA2301515A1 (de)
DE (1) DE69816632T2 (de)
ES (1) ES2202890T3 (de)
WO (1) WO1999010348A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99513A0 (en) * 1990-09-20 1992-08-18 Hoechst Ag Process for the preparation of carbapenem compounds

Also Published As

Publication number Publication date
ES2202890T3 (es) 2004-04-01
JP2002503636A (ja) 2002-02-05
DE69816632D1 (de) 2003-08-28
DE69816632T2 (de) 2004-06-03
JP3386452B2 (ja) 2003-03-17
EP1015452A4 (de) 2001-07-11
AU9115798A (en) 1999-03-16
WO1999010348A1 (en) 1999-03-04
EP1015452A1 (de) 2000-07-05
CA2301515A1 (en) 1999-03-04
EP1015452B1 (de) 2003-07-23
AU731494B2 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
YU34896A (sh) Supstituisani n-(indol-2-karbonil)-glicinamidi, njihovi intermedijeri i farmaceutske kompozicije
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
FI931888A0 (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
DE69331089D1 (de) Beta-Laktam und Cepham Verbindungen und Ihre Herstellung
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
ATE191485T1 (de) Mercaptoacetylamid-1,3,4,5- tetrahydrobenzo(c)azepin-3-ein disulfidderivate als enkephalinase und ace inhibitoren
DE69717970D1 (de) Chinolin carbonsaure-derivate und ihre salze
PT918776E (pt) Sintese total de acilfulvenos antitumorais
ATE254127T1 (de) Stabilisierte carbapenem-zwischenprodukteund ihre verwendung in der synthese
GB9810659D0 (en) Organic compounds
ATE228520T1 (de) Lactamverbindungen als inhibitoren der cholesterin-esterase
ATE245647T1 (de) Gegebenenfalls geschützte 3- hydroxymethylcarbapeneme und ihre synthese
EP0987255A3 (de) Substituierte Aminochinazolinon (thion) Derivate
PL312471A1 (en) Benzene derivatives effective in ischaemia diseases
WO2001044182A3 (en) New synthesis of spla2 inhibitors
DK1183250T3 (da) Semisyntese af paclitaxel under anvendelse af dialkyldichlorsilaner
GB9523637D0 (en) Synthesis of carboxylic acid derivatives
AU7332996A (en) Therapeutics for thrombocytopenia
ATE106871T1 (de) Pyridinderivate und verfahren zu ihrer synthese.
EP0971889A4 (de) Verfahren zur herstellung von zwischenprodukten des carbapenems
MX9604347A (es) Derivados del acido 2-(4-pirazoliloxi-pirimidin-5-il) acetico.
AU1735397A (en) Pyridonecarboxylic acid derivatives and intermediates for the synthesis thereo
CA2334820A1 (en) Process for the synthesis of carbapenem intermediates, and compounds produced
EP1007511A4 (de) Herstellung von beta-mehtylcarbapenem-zwischenprodukten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties